Help your patients save on their ZTlido prescription and 
refills with the Copay Savings Card

How it works

Write a ZTlido prescription

Write a ZTlido prescription

for your patient

Present card to pharmacist

Patient presents the card

to their pharmacist

Pay as little as

Patient pays as little as $0

on their first prescription 
and on each monthly refill*

*Offer valid on prescriptions for ZTlido product only.

Restrictions apply. Not valid for patients eligible for benefits under Medicaid (including 
Medicaid managed care), Medicare, TRICARE, Veterans Affairs, FEHBP, or similar state 
or federal programs. Offer good only in the USA and Puerto Rico.

Prescribing ZTlido

Apply up to 3 patches


For 12 hours (within 24 hours)


(within 24 hours)

30 patches per carton



WRITE DAW to make sure ZTlido is dispensed as written (not replaced with generic)

Write the appropriate number of refills

ZTlido is not A/B rated and therefore not substitutable with lidocaine 5% patches.

When ZTlido® coverage requires prior authorization, 
we support you and your patients from the start

You want your patients to get exactly what you prescribe—without compromise and without delay—and we're here to help.

When prior authorization is needed, we can help you:



Whether you prefer to prescribe online or by fax, we help you find the appropriate information and/or forms to start the process.



Within 24 business hours after getting the necessary information from you, we connect with your patients to discuss coverage and shipping.



Once copay benefits are processed (if eligible), we help to connect your patient with a local pharmacy or set up delivery by mail.

Contact your sales representative for more information.

Important Safety Information


ZTLIDO is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.

Warnings and Precautions

Accidental exposure can occur even after a ZTLIDO patch has been used. Small children or pets could suffer serious adverse effects from chewing or ingesting a new or used ZTLIDO patch. Store and dispose of patches properly and keep out of reach of children and pets.

Excessive dosing or overexposure to lidocaine can occur. Longer duration of application, application of more than the recommended number of patches, smaller patients, or impaired elimination may all contribute to increased blood concentration levels of lidocaine. If lidocaine overdose is suspected, check drug blood concentration. Management of overdose includes close monitoring, supportive care, and symptomatic treatment.

Cases of methemoglobinemia have been reported with local anesthetic use, although patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, or concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. Signs and symptoms include cyanotic skin discoloration and/or abnormal coloration of the blood and may occur immediately or may be delayed after exposure. Methemoglobin levels may continue to rise leading to more serious central nervous system and cardiovascular adverse effects. Discontinue ZTLIDO and any other oxidizing agents. Depending on severity of the symptoms, patients may respond to supportive care or may require treatment with methylene blue, exchange transfusion, or hyperbaric oxygen.

Application site reactions can occur during or immediately after treatment with ZTLIDO. This may include development of blisters, bruising, burning sensation, depigmentation, dermatitis, discoloration, edema, erythema, exfoliation, irritation, papules, petechia, pruritus, vesicles, or may be the locus of abnormal sensation. These reactions are generally mild and transient, resolving spontaneously within a few minutes to hours. Inform patients of these potential reactions and that severe skin irritation may occur with ZTLIDO if applied for a longer period than instructed.

Hypersensitivity cross-reactions may be possible for patients allergic to PABA derivatives. Manage hypersensitivity reactions by conventional means.

Eye exposure with ZTLIDO should be avoided. If eye contact occurs, immediately wash out the eye with water or saline and protect the eye (eg, eye glasses/eye wear) until sensation returns.

Adverse Reactions

Side effects of ZTLIDO include application site reactions such as, irritation, erythema, and pruritus. These are not all of the adverse reactions that may occur. Please see full Prescribing Information for more information.

Use in Specific Populations

Use of ZTLIDO during lactation should be used with caution as lidocaine is excreted into breast milk. The limited human data with lidocaine in pregnant women are not sufficient to inform drug-associated risk for major birth defects and miscarriage.

To report SUSPECTED ADVERSE REACTIONS, contact SCILEX Pharmaceuticals Inc. at 1-866-SCILEX3 or contact FDA at 1-800-FDA-1088 or

Please see full Prescribing Information.

Help your patients get 
the ZTlido® you prescribe

Important Safety Information


ZTLIDO is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.

Read More